Sfoglia per AUTORE
BENNATI C
Collezione AOU Novara
Items : 2
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1?50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry. in Journal for immunotherapy of cancer / J Immunother Cancer. 2025 Feb 4;13(2):e010674. doi: 10.1136/jitc-2024-010674.
2025
AOU San Luigi di Orbassano
AOU Novara
AOU San Luigi di Orbassano
AOU Novara
Wakelee H; Garassino M; Peters S; Takada K; Naqash AR; Torri V; Hejleh TA; Ferrara R; Aerts JGJV; Aboubakar Nana F; Dingemans AM; Biello F; Rogado J; Moliner L; Beninato T; Lo Russo G; Servetto A; Mezquita L; Gorría T; Minuti G; Bennati C; Tonini G; Cortinovis DL; Agustoni F; Majem M; Baena J; Macerelli M; Monnet I; O'Reilly D; et alii...
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research. in Clinical lung cancer / Clin Lung Cancer. 2024 Mar;25(2):190-195. doi: 10.1016/j.cllc.2023.12.012. Epub 2023 Dec 22.
2024
AOU Novara
AOU Novara
Beninato T; Manglaviti S; Occhipinti M; Vigorito R; Greco GF; Ruggirello M; Calareso G; Mazzoni F; Sangaletti S; Agnelli L; Lorenzini D; Auletta P; Trovò F; Grisanti S; Vita E; Spinelli G; Tartarone A; Aieta M; Buzzacchino F; Lugini A; Pisconti S; Bareggi C; Verderame F; Emili R; Macerelli M; Pecci F; Cantini L; Berardi R; Bertolini F; et alii...